» Articles » PMID: 34277747

Colloids Yes or No? - a "Gretchen Question" Answered

Overview
Journal Front Vet Sci
Date 2021 Jul 19
PMID 34277747
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Colloid solutions, both natural and synthetic, had been widely accepted as having superior volume expanding effects than crystalloids. Synthetic colloid solutions were previously considered at least as effective as natural colloids, as well as being cheaper and easily available. As a result, synthetic colloids (and HES in particular) were the preferred resuscitation fluid in many countries. In the past decade, several cascading events have called into question their efficacy and revealed their harmful effects. In 2013, the medicines authorities placed substantial restrictions on HES administration in people which has resulted in an overall decrease in their use. Whether natural colloids (such as albumin-containing solutions) should replace synthetic colloids remains inconclusive based on the current evidence. Albumin seems to be safer than synthetic colloids in people, but clear evidence of a positive effect on survival is still lacking. Furthermore, species-specific albumin is not widely available, while xenotransfusions with human serum albumin have known side effects. Veterinary data on the safety and efficacy of synthetic and natural colloids is limited to mostly retrospective evaluations or experimental studies with small numbers of patients (mainly dogs). Large, prospective, randomized, long-term outcome-oriented studies are lacking. This review focuses on advantages and disadvantages of synthetic and natural colloids in veterinary medicine. Adopting human guidelines is weighed against the particularities of our specific patient populations, including the risk-benefit ratio and lack of alternatives available in human medicine.

Citing Articles

Albumin: a comprehensive review and practical guideline for clinical use.

Abedi F, Zarei B, Elyasi S Eur J Clin Pharmacol. 2024; 80(8):1151-1169.

PMID: 38607390 DOI: 10.1007/s00228-024-03664-y.


A Comparison of Dobutamine, Norepinephrine, Vasopressin, and Hetastarch for the Treatment of Isoflurane-Induced Hypotension in Healthy, Normovolemic Dogs.

Henao-Guerrero N, Ricco-Pereira C, Paranjape V Animals (Basel). 2023; 13(16).

PMID: 37627465 PMC: 10451654. DOI: 10.3390/ani13162674.


ENGINEERED INTRAVENOUS THERAPIES FOR TRAUMA.

Pichon T, White N, Pun S Curr Opin Biomed Eng. 2023; 27.

PMID: 37456984 PMC: 10343715. DOI: 10.1016/j.cobme.2023.100456.


Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era.

Ling H, Lou X, Luo Q, He Z, Sun M, Sun J Acta Pharm Sin B. 2022; 12(12):4348-4364.

PMID: 36561998 PMC: 9764073. DOI: 10.1016/j.apsb.2022.05.007.


Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study.

Adamik K, Stoffel M, Tangermann S, Dietler B, Stokar-Regenscheit N Front Vet Sci. 2022; 8:802507.

PMID: 35071392 PMC: 8770911. DOI: 10.3389/fvets.2021.802507.

References
1.
Schmid S, Cianciolo R, Drobatz K, Sanchez M, Price J, King L . Postmortem evaluation of renal tubular vacuolization in critically ill dogs. J Vet Emerg Crit Care (San Antonio). 2019; 29(3):279-287. DOI: 10.1111/vec.12837. View

2.
Morgan T, Little J . Renal failure and low-molecular-weight dextran. Br Med J. 1967; 1(5540):635. PMC: 1841425. DOI: 10.1136/bmj.1.5540.635-c. View

3.
Loyd K, Cocayne C, Cridland J, Hause W . Retrospective evaluation of the administration of 25% human albumin to dogs with protein-losing enteropathy: 21 cases (2003-2013). J Vet Emerg Crit Care (San Antonio). 2016; 26(4):587-92. DOI: 10.1111/vec.12484. View

4.
Jacob M, Rehm M, Orth V, Lotsch M, Brechtelsbauer H, Weninger E . [Exact measurement of the volume effect of 6% hydoxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution]. Anaesthesist. 2003; 52(10):896-904. DOI: 10.1007/s00101-003-0557-0. View

5.
Komaromi A, Estenberg U, Hammarqvist F, Rooyackers O, Wernerman J, Norberg A . Simultaneous assessment of the synthesis rate and transcapillary escape rate of albumin in inflammation and surgery. Crit Care. 2016; 20(1):370. PMC: 5111293. DOI: 10.1186/s13054-016-1536-6. View